Evidence map›Paper›PMID 40153074›Full record

ReviewRheumatology international2025

Ηidradenitis suppurativa associated with autoimmunity in children and adolescents; a case-based review.

Maria M Berikopoulou, Argyro Konstantopoulou, Sotirios Argyrakis, Maria Theochari, Panagiota Drosatou, Anna Messaritaki, Dimitra Dimopoulou

Abstract readCase ReportsReview
PubMed Publisher
In one paragraph

Review in Rheumatology international, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Maria M Berikopoulou *Second Department of Pediatrics, Children's Hospital "Aghia Sofia", Athens, Greece.ORCID 0000-0002-0018-6584
Argyro Konstantopoulou *Second Department of Pediatrics, Children's Hospital "Aghia Sofia", Athens, Greece.ORCID 0009-0005-2131-0926
Sotirios ArgyrakisSecond Department of Pediatrics, Children's Hospital "Aghia Sofia", Athens, Greece.ORCID 0009-0008-4911-1912
Maria TheochariSecond Department of Pediatrics, Children's Hospital "Aghia Sofia", Athens, Greece.ORCID 0009-0008-8916-2407
Panagiota DrosatouSecond Department of Pediatrics, Children's Hospital "Aghia Sofia", Athens, Greece.ORCID 0009-0003-6315-8817
Anna MessaritakiSecond Department of Pediatrics, Children's Hospital "Aghia Sofia", Athens, Greece.ORCID 0009-0007-5486-8701
Dimitra DimopoulouSecond Department of Pediatrics, Children's Hospital "Aghia Sofia", Athens, Greece. dimi_med@hotmail.com.ORCID 0000-0003-4470-263X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hidradenitis suppurativa (HS) is an uncommon chronic inflammatory disease in children, characterized by painful abscesses and lesions. It has been associated with various autoimmune conditions, including inflammatory bowel diseases (IBDs) and rheumatologic disorders. We present a 13-year-old female with Hurley stage III HS, who developed macrophage activation syndrome (MAS). Clinical presentation and laboratory findings led to a diagnosis of systemic lupus erythematosus (SLE). Treatment with immunosuppressive therapy resulted in symptom resolution and clinical improvement. In addition, a case-based review was conducted to evaluate the patterns, clinical features and possible underlying mechanisms in the pediatric patients with HS and autoimmune diseases. Twenty pediatric cases were included with a median HS onset age of 15 years (IQR: 4 years). Among these, 55% were diagnosed with IBDs, followed by autoimmune arthritis and psoriasis (10% each). Treatment was individualized, with 95% receiving biologic agent and 55% receiving antimicrobials. This case and case-based review of literature highlight the potential overlap between HS and autoimmunity, especially SLE, in the pediatric population and emphasize the importance of proactive monitoring for coexisting autoimmune diseases in patients with HS, in order to facilitate early detection and effective management.

Indexed as

AutoimmunityHidradenitis SuppurativaLupus Erythematosus, SystemicMacrophage Activation SyndromeAdolescentFemaleHumansImmunosuppressive AgentsImmunosuppressive AgentsAdolescentAutoimmune diseasesChildHidradenitis suppurativaSystemic lupus erythematosus

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.